Song-Yu Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Song-Yu Guo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Shao Li
Department of Physiology, College of Basic Medical Sciences, Liaoning Provincial Key Laboratory of Cerebral Diseases, Dalian Medical University, Dalian, China
2 shared publications Ao-Ran Sui
Department of Physiology, College of Basic Medical Sciences, Liaoning Provincial Key Laboratory of Cerebral Diseases, Dalian Medical University, Dalian, China
1 shared publication- Ao-Ran Sui
Department of Physiology, College of Basic Medical Sciences, Liaoning Provincial Key Laboratory of Cerebral Diseases, National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China
1 shared publication Dan Zhao
Department of Geriatrics, Affiliated Dalian Friendship Hospital of Dalian Medical University, Dalian, China
1 shared publication- Jianmei Ma
Department of Anatomy, Dalian Medical University, Dalian, China
1 shared publication - Jie Zhao
National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China
1 shared publication
Latest Publications
- 11 September 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 264
SVHRSP Attenuates PTZ-Induced Seizure-Like Behavior in C. elegans: Involvement of HSF-1 and Associated Changes in GABAergic Markers and Mitochondrial Homeostasis
Epilepsy is a prevalent neurological disorder. Nevertheless, approximately one-third of patients fail to achieve sufficient seizure control through current pharmacological treatments. This unmet need underscores the importance of developing new antiseizure treatments for drug-resistant epilepsy. Scorpion venom heat-resistant synthetic peptide (SVHRSP), which is derived from scorpion venom and chemically synthesized, has demonstrated promising activity against acute PTZ-evoked seizure-like behaviors. In this study, the effects of SVHRSP pretreatment on acute PTZ-evoked seizure-like behavior were evaluated in Caenorhabditis elegans. Our findings indicate that SVHRSP (50 μM) significantly alleviated the seizure-like behavioral symptoms induced by PTZ (30 mg/mL). Specifically, behavioral assessments showed that SVHRSP improved survival and attenuated PTZ-associated deficits in locomotion, food preference, chemotaxis, and pharyngeal pumping in PTZ-exposed nematodes. Furthermore, SVHRSP pretreatment partially reversed PTZ-associated changes in GABAergic and glutamatergic reporter fluorescence and in the transcript abundance of unc-25, gat-1, and eat-4. SVHRSP also ameliorated mitochondrial dysfunction and reduced oxidative stress. SVHRSP pretreatment was also associated with increased ced-9 transcript abundance, reduced cep-1 transcript abundance, lower intracellular ferrous iron (Fe2+) levels, and attenuation of PTZ-associated changes in GABAergic reporter morphology. The attenuation of these SVHRSP-associated changes in hsf-1(sy441) animals supports the involvement of HSF-1-dependent processes; however, direct HSF-1 activation and the downstream causal relationships were not established. These findings show that SVHRSP pretreatment attenuated acute PTZ-evoked seizure-like phenotypes in C. elegans and support further evaluation in mammalian seizure and epilepsy models.
- 11 September 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 264
SVHRSP Attenuates PTZ-Induced Seizure-Like Behavior in C. elegans: Involvement of HSF-1 and Associated Changes in GABAergic Markers and Mitochondrial Homeostasis
Epilepsy is a prevalent neurological disorder. Nevertheless, approximately one-third of patients fail to achieve sufficient seizure control through current pharmacological treatments. This unmet need underscores the importance of developing new antiseizure treatments for drug-resistant epilepsy. Scorpion venom heat-resistant synthetic peptide (SVHRSP), which is derived from scorpion venom and chemically synthesized, has demonstrated promising activity against acute PTZ-evoked seizure-like behaviors. In this study, the effects of SVHRSP pretreatment on acute PTZ-evoked seizure-like behavior were evaluated in Caenorhabditis elegans. Our findings indicate that SVHRSP (50 μM) significantly alleviated the seizure-like behavioral symptoms induced by PTZ (30 mg/mL). Specifically, behavioral assessments showed that SVHRSP improved survival and attenuated PTZ-associated deficits in locomotion, food preference, chemotaxis, and pharyngeal pumping in PTZ-exposed nematodes. Furthermore, SVHRSP pretreatment partially reversed PTZ-associated changes in GABAergic and glutamatergic reporter fluorescence and in the transcript abundance of unc-25, gat-1, and eat-4. SVHRSP also ameliorated mitochondrial dysfunction and reduced oxidative stress. SVHRSP pretreatment was also associated with increased ced-9 transcript abundance, reduced cep-1 transcript abundance, lower intracellular ferrous iron (Fe2+) levels, and attenuation of PTZ-associated changes in GABAergic reporter morphology. The attenuation of these SVHRSP-associated changes in hsf-1(sy441) animals supports the involvement of HSF-1-dependent processes; however, direct HSF-1 activation and the downstream causal relationships were not established. These findings show that SVHRSP pretreatment attenuated acute PTZ-evoked seizure-like phenotypes in C. elegans and support further evaluation in mammalian seizure and epilepsy models.
- Open Access
- 21 May 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (6) , 628
SVHRSP Alleviates Age-Related Cognitive Deficiency by Reducing Oxidative Stress and Neuroinflammation
Background: Our previous studies have shown that scorpion venom heat-resistant synthesized peptide (SVHRSP) induces a significant extension in lifespan and improvements in age-related physiological functions in worms. However, the mechanism underlying the potential anti-aging effects of SVHRSP in mammals remains elusive. Methods: Following SVHRSP treatment in senescence-accelerated mouse resistant 1 (SAMR1) or senescence-accelerated mouse prone 8 (SAMP8) mice, behavioral tests were conducted and brain tissues were collected for morphological analysis, electrophysiology experiments, flow cytometry, and protein or gene expression. The human neuroblastoma cell line (SH-SY5Y) was subjected to H2O2 treatment in cell experiments, aiming to establish a cytotoxic model that mimics cellular senescence. This model was utilized to investigate the regulatory mechanisms underlying oxidative stress and neuroinflammation associated with age-related cognitive impairment mediated by SVHRSP. Results: SVHRSP significantly ameliorated age-related cognitive decline, enhanced long-term potentiation, restored synaptic loss, and upregulated the expression of synaptic proteins, therefore indicating an improvement in synaptic plasticity. Moreover, SVHRSP demonstrated a decline in senescent markers, including SA-β-gal enzyme activity, P16, P21, SIRT1, and cell cycle arrest. The underlying mechanisms involve an upregulation of antioxidant enzyme activity and a reduction in oxidative stress-induced damage. Furthermore, SVHRSP regulated the nucleoplasmic distribution of NRF2 through the SIRT1-P53 pathway. Further investigation indicated a reduction in the expression of proinflammatory factors in the brain after SVHRSP treatment. SVHRSP attenuated neuroinflammation by regulating the NF-κB nucleoplasmic distribution and inhibiting microglial and astrocytic activation through the SIRT1-NF-κB pathway. Additionally, SVHRSP significantly augmented Nissl body count while suppressing neuronal loss. Conclusion: SVHRSP could remarkably improve cognitive deficiency by inhibiting oxidative stress and neuroinflammation, thus representing an effective strategy to improve brain health.
- 21 May 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (6) , 628
Open AccessSVHRSP Alleviates Age-Related Cognitive Deficiency by Reducing Oxidative Stress and Neuroinflammation
Background: Our previous studies have shown that scorpion venom heat-resistant synthesized peptide (SVHRSP) induces a significant extension in lifespan and improvements in age-related physiological functions in worms. However, the mechanism underlying the potential anti-aging effects of SVHRSP in mammals remains elusive. Methods: Following SVHRSP treatment in senescence-accelerated mouse resistant 1 (SAMR1) or senescence-accelerated mouse prone 8 (SAMP8) mice, behavioral tests were conducted and brain tissues were collected for morphological analysis, electrophysiology experiments, flow cytometry, and protein or gene expression. The human neuroblastoma cell line (SH-SY5Y) was subjected to H2O2 treatment in cell experiments, aiming to establish a cytotoxic model that mimics cellular senescence. This model was utilized to investigate the regulatory mechanisms underlying oxidative stress and neuroinflammation associated with age-related cognitive impairment mediated by SVHRSP. Results: SVHRSP significantly ameliorated age-related cognitive decline, enhanced long-term potentiation, restored synaptic loss, and upregulated the expression of synaptic proteins, therefore indicating an improvement in synaptic plasticity. Moreover, SVHRSP demonstrated a decline in senescent markers, including SA-β-gal enzyme activity, P16, P21, SIRT1, and cell cycle arrest. The underlying mechanisms involve an upregulation of antioxidant enzyme activity and a reduction in oxidative stress-induced damage. Furthermore, SVHRSP regulated the nucleoplasmic distribution of NRF2 through the SIRT1-P53 pathway. Further investigation indicated a reduction in the expression of proinflammatory factors in the brain after SVHRSP treatment. SVHRSP attenuated neuroinflammation by regulating the NF-κB nucleoplasmic distribution and inhibiting microglial and astrocytic activation through the SIRT1-NF-κB pathway. Additionally, SVHRSP significantly augmented Nissl body count while suppressing neuronal loss. Conclusion: SVHRSP could remarkably improve cognitive deficiency by inhibiting oxidative stress and neuroinflammation, thus representing an effective strategy to improve brain health.